- Home
- AFCG vs TLPH Comparison
AFCG vs TLPH Comparison
Compare AFCG & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AFCG | TLPH |
|---|---|---|
| Founded | 2020 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.4M | 70.3M |
| IPO Year | 2020 | 2010 |
Fundamental Metrics
Financial Performance| Metric | AFCG | TLPH |
|---|---|---|
| Price | $3.15 | $1.22 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.50 | N/A |
| AVG Volume (30 Days) | 71.2K | ★ 265.5K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | ★ 6.94% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $24,563,601.00 | $2,151,000.00 |
| Revenue This Year | $1,334.03 | N/A |
| Revenue Next Year | $17.33 | N/A |
| P/E Ratio | $4.18 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.06 | $0.40 |
| 52 Week High | $5.10 | $1.57 |
Technical Indicators
Market Signals| Indicator | AFCG | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 65.34 | 42.69 |
| Support Level | $3.06 | $0.74 |
| Resistance Level | $3.37 | $1.29 |
| Average True Range (ATR) | 0.12 | 0.10 |
| MACD | 0.05 | -0.03 |
| Stochastic Oscillator | 87.72 | 22.82 |
Price Performance
Historical ComparisonAbout AFCG AFC Gamma Inc.
Advanced Flower Capital Inc is an externally managed Maryland corporation that operates as a Business Development Company (BDC). The firm's primary operations involve originating, structuring, underwriting, and managing senior secured loans and other debt securities. Its investment portfolio includes loans to state law-compliant cannabis operators, ancillary cannabis businesses, and middle-market companies in other industries. These loans are typically secured by collateral such as real estate, equipment, cash flows, and license values.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.